Mato just raised pre-seed Read more
Podcast charts
Published by ATTD on UNLOK
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
The Mato Topic Intelligence Platform does not report this podcast as charting in a published category in this snapshot.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
In this inaugural episode of ATTD Diabetes Talks: The Power of Weekly Insulin , we delve into the evolution and future of basal insulin therapy. Host Diana Isaacs sits down with Dr. Rodolfo Galindo to explore the pharmacological innovations behind weekly insulin formulations and discuss how this breakthrough is reshaping modern diabetes management. Guest: Dr. Rodolfo Galindo (Associate Professor of Medicine and Director of the Comprehensive Diabetes Center at the University of Miami Health System) Key Topics Covered: The Evolution of Basal Insulin: A look back at the progression from early long-acting formulations to current weekly treatment options. Pharmacological Innovation: Understanding the science that makes weekly insulin formulations possible. Clinical Advantages: Exploring the theoretical benefits of weekly versus daily basal insulin. Patient Impact: Examining how shifting to a weekly regimen affects treatment burden and overall patient experience. Future Outlook: How weekly insulin is poised to fit into the broader landscape of diabetes care. Resources: For more in-depth knowledge and exclusive content, visit the ATTD Education Portal . Subscribe to the podcast to stay updated on the latest in diabetes management.
Join host Dr. David Ahn and guest Dr. Michael Haller (Professor and Chief of Pediatric Endocrinology at the University of Florida and Chair of TrialNet) as they take a comprehensive review of the evidence base and remaining gaps for inhaled insulin use in pediatric and adolescent populations In this final episode, we dive into: Key Challenges in Pediatrics: Unmet needs in pediatric insulin therapy, including injection fatigue and tech-retention issues for active youth. The INHALE-1 Study: A deep dive into the randomized controlled trial data of 230 youth, highlighting efficacy, per-protocol non-inferiority, less weight gain, and superior treatment satisfaction among kids and parents. Safety Profile: Analyzing forced expiratory volume (FEV1) data showing an excellent safety signal with no differences in pulmonary function or severe hypoglycemic events. Practical Toolkit Use Cases: How the unique pharmacokinetic profile of inhaled insulin provides unmatched benefits for covering adrenaline-rush highs and avoiding hypoglycemia tail effects during sports and exercise. Dosing Guidelines: Overcoming the practical "paradigm shift" of converting injected units to inhaled units and managing dosing effectively. Future Horizons: Anticipating the "INHALE FIRST" study investigating early onboarding for newly diagnosed patients and introducing a new two-unit inhaled insulin cartridge. About ATTD Diabetes Talks: A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation. Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/ Subscribe to the podcast for more updates on advancing diabetes care. #DiabetesManagement #PediatricEndocrinology #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Type1Diabetes Chapters: 00:00 Intro and Unique Challenges in Pediatric Diabetes Management 02:38 The INHALE-1 Study: Efficacy, Satisfaction, and Weight Findings 06:27 Safety Signals, Pulmonary Function, and Adherence Challenges 10:18 Practical Toolkit Use Cases: Managing Sports and Exercise 12:48 Dosing Conversions and Practical Patient Selection Guidelines 15:02 Off-Label Integration with Automated Insulin Delivery (AID) Systems 20:14 Caregiver & School Nurse Roles and Managing Safety Concerns 22:00 Research Gaps, The INHALE FIRST Trial, and Wrap Up
Join host Dr. David Ahn and guest Dr. Roy Beck (Founder and Medical Director of the Jaeb Center for Health Research) as they explore the integration of inhaled insulin with automated insulin delivery (AID) systems. In this episode, we dive into: The potential of combining inhaled insulin with current AID technologies. Theoretical advantages, including postprandial management. Current evidence, clinical considerations, and existing evidence gaps. Practical insights for clinicians on patient education and system integration. About ATTD Diabetes Talks: A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation. Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/ Subscribe to the podcast for more updates on advancing diabetes care. #DiabetesManagement #AIDSystems #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Endocrinology Chapters: 00:00 Intro 03:03 How Inhaled Insulin Works 07:30 Real World Dosing Workflow 10:24 Exercise and Safety Upside 15:45 Clinician Education Tips 17:38 Research Gaps and Trials Needed 19:32 Future Potential and Wrap Up
In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation. Key discussion points: Defining therapeutic inertia in the context of insulin initiation. Common clinician and patient-related barriers that contribute to treatment delays. Practical strategies for introducing inhaled insulin to hesitant patients. System-level considerations, including workflow and reimbursement challenges. Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/ Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together. #DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcast Chapters: 00:00 Why Inhaled Insulin Matters 00:34 Show Intro and Guest 01:22 Defining Therapeutic Inertia 02:19 Clinician Barriers to Insulin 03:49 Patient Fears and Hesitation 05:28 How Inhaled Insulin Helps 07:00 Best Fit Patient Scenarios 08:22 Talking to Hesitant Patients 10:39 Workflow and Coverage Hurdles 13:35 PFT Testing and Side Effects 14:47 Future Role and Wrap Up
In our new series, The Role of Inhaled Insulin, host Dr David Ahn looks at the practical implementation of inhaled insulin in clinical practice. He is joined by Dr Irl Hirsch. They discuss: Where inhaled insulin fits today within the overall insulin therapy landscape The best candidates for inhaled insulin in routine clinical practice Key clinical factors to guide decision-making Practical first steps to initiating inhaled insulin Approaches to titration Monitoring strategies, particularly regarding pulmonary safety and glycemic outcomes Shared decision-making and engaging patients Dr Irl Hirsch is Professor of Medicine, in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington School of Medicine. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy. They discuss: The most common mistakes or misconceptions in basal insulin initiation and management Intensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinations Leveraging technologies to improve insulin adherence and outcomes Managing hypoglycemia concerns and achieving glycemic targets Addressing psychological and behavioral barriers to insulin use in everyday clinical practice Dr Elena Toschi is Assistant Professor of Medicine at Harvard Medical School. She’s also Director of the Young Adult Program and a member of the Diabetes Technology Program at the Joslin Diabetes Center. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations. They discuss: Why personalization is particularly important in insulin therapy The patient groups most in need of a tailored approach How comorbidities or frailty influence insulin decision-making Guidelines, flexibility, and local solutions Dr Peters is a Professor of Medicine at the Keck School of Medicine of USC, and Director of the USC Clinical Diabetes Programs. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients. They discuss: The barriers most misunderstood by clinicians Communication and motivational interviewing with patients Emotional burden and fear of hypoglycemia Practical strategies clinicians can use to support patients more effectively The role of the wider diabetes healthcare team Diana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education. They discuss: Why hypoglycemia remains a major concern in insulin therapy Key risk factors to keep in mind Clinical signs or patient-reported symptoms Prevention strategies Importance of patient education Balancing glycemic targets with hypoglycemia risk Prof. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support. They discuss: The new technologies making the biggest difference in insulin therapy today The role of smart pens, connected devices, and apps Biggest clinical impact - including adherence, titration and outcomes Accessibility of these tools in real-world practice Advisor role of AI The promising future of technology in insulin therapy and a functional cure Professor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations. They discuss: What exactly fixed-ratio combinations are and the problems they tackle Identifying patient candidates and timelines for starting FRCs Meaningful benefits of FRCs compared with basal insulin alone Concerns and limitations of FRCs How guideline recommendations currently position FRCs in diabetes management Dr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient. They discuss: The importance of titration in successful insulin therapy Barriers to titration, including patient self-management How clinicians can collaborate with patients in their titration journey The importance of language used by clinicians Practical tips for simplifying titration in busy clinical settings Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes. They discuss: When clinicians should consider insulin for patients with T2D Addressing concerns of weight gain with insulin ADA/EASD recommendations Barriers to insulin therapy and Type 2 diabetes Advice on communication with patients Dr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use. He is joined by Dr Giulio Romeo. They discuss: The role of basal insulin in normal physiology and why it matters in Type 2 diabetes Goals of basal insulin therapy What makes new basal insulins different Current guidelines and recommendations for basal insulin therapy Alternatives to basal insulin therapy Tips for safe and effective initiation and titration Dr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School. Explore more on the ATTD Education Portal . Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode of ATTD 2026 Conference Catch-Up , we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy , featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies. Join us as we summarize key takeaways from these thought-provoking presentations: Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
In this episode of ATTD 2026 Conference Catch-Up , we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care , where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use. Join us as we summarize key takeaways from these thought-provoking presentations: Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
In this episode of ATTD 2026 Conference Catch-Up , we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas , exploring innovative applications of CGM beyond its conventional use in diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews Non-invasive Glucose Monitoring – Dr. Lutz Heinemann CGM Use in Clinical Trials – Prof. Pratik Choudhary This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes , featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes. While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population. Join us as we summarize key takeaways from these thought-provoking presentations: • Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel • Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell • Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard • Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com
In this episode of ATTD 2026 Conference Catch-Up , we dive into Refining Care of Type 1 Diabetes , featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Refining Care of Type 1 Diabetes – Dr. Lori Laffel Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com
In this episode of ATTD 2026 Conference Catch-Up , we dive into Managing Overweight & Obesity in Type 1 Diabetes , featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes. As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond glycemic control. This session explores the role of behavioral, nutritional, and therapeutic approaches in supporting sustainable weight management while maintaining optimal diabetes outcomes. Join us as we summarize key takeaways from these thought-provoking presentations: • The Role of Psychological Interventions in Promoting Sustainable Weight Loss – Alon Liberman • Essential Nutrition Support for GLP-1/GIP Therapy Success – Dr. Adrian Brown • Beyond Glycemia: Addressing Overweight and Obesity in Type 1 Diabetes – Prof. Lia Bally This episode is an essential listen for endocrinologists, diabetologists, dietitians, and healthcare professionals involved in diabetes care looking to better understand multidisciplinary approaches to weight management in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed September 18, 2026. Cached outside the daily freshness window; the positions keep the date they were taken on.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.